T1	Participants 81 124	autism and pervasive developmental disorder
T2	Participants 529 610	60 children (age, 3 to 14 years) with autism or pervasive developmental disorder.
T3	Participants 1030 1143	60 children, 4 could not be evaluated - 2 received secretin outside the study, and 2 did not return for follow-up
T4	Participants 1151 1181	56 children (28 in each group)
T5	Participants 1339 1347	children
T6	Participants 1799 1807	children
T7	Participants 1900 1923	parents of the children
